Ahmet Ozen

Dr. Ahmet Ozen


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2019 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
LCLouis-Marie Charbonnier
Louis-Marie Charbonnier
YCYe Cui
Ye Cui
ESEmmanuel Stephen-Victor
Emmanuel Stephen-Victor
Hani HarbHani Harb
Hani Harb
DLDavid Lopez
David Lopez
TCTalal A. Chatila
Talal A. Chatila

9 November 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
Piotr RzymskiPiotr Rzymski
Piotr Rzymski
CCCarlos A Camargo
Carlos A Camargo
AFAndrzej Fal
Andrzej Fal
Robert FlisiakRobert Flisiak
Robert Flisiak
Willis GwenziWillis Gwenzi
Willis Gwenzi
NRNima Rezaei
Nima Rezaei
Pursuing vaccinations against COVID-19 brings hope to limit the spread of SARS-CoV-2 and remains the most rational decision under pandemic conditions. However, it does not come without challenges, including temporary shortages in vaccine doses, significant vaccine inequity, and questions regarding the durability of vaccine-induced immunity that remain unanswered. Moreover, SARS-CoV-2 has undergone evolution with the emergence of its novel variants, characterized by enhanced transmissibility and ability to at least partially evade neutralizing antibodies. At the same time, serum antibody levels start to wane within a few months after vaccination, ultimately increasing the risk of breakthrough infections. This article discusses whether the administration of booster doses of COVID-19 vaccines is urgently needed to control the pandemic. We conclude that, at present, optimizing the immunity level of wealthy populations cannot come at the expense of low-income regions that suffer from vaccine unavailability. Although the efficiency of vaccination in protecting from infection may decrease over time, current data show that efficacy against severe disease, hospitalization, and death remains at a high level. If vaccine coverage continues at extremely low levels in various regions, including African countries, SARS-CoV-2 may sooner or later evolve into variants better adapted to evade natural and vaccine-induced immunity, ultimately bringing a global threat that, of course, includes wealthy populations. We offer key recommendations to increase vaccination rates in low-income countries. The pandemic is, by definition, a major epidemiological event and requires looking beyond one’s immediate self-interest; otherwise, efforts to contain it will be futile.

30 August 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
ÖBÖzge Besci̇
Özge Besci̇
DBDilek Başer
Dilek Başer
IÖİsMail Öğülür
İsMail Öğülür
ABAyşe Cansu BERBEROĞLU
Ayşe Cansu BERBEROĞLU
AKAyca Kiykim
Ayca Kiykim
EKElif Karakoc-Aydıner
Elif Karakoc-Aydıner
Established reference values are critical for the interpretation of immunologic assessments. In particular, the proportion and absolute counts of T- and B- cell subpopulations are subject to change with age and ethnicity. We aimed to establish age-specific reference values for lymphocyte subsets using updated immunophenotyping panels. We studied a total of 297 healthy Turkish subjects aged 0 to 50 years, stratified into major age brackets in a cluster factor of 10 per age-group. The predetermined age intervals contained randomly allocated participants enrolled over a period of 6 months, who were homogenously distributed by gender. We analyzed a complete blood count test and simultaneously with detailed immunophenotyping enumerated the percent and absolute cell counts of lymphocyte subsets. The percentage and absolute counts of lymphocyte subsets show a marked surge across the age-span. T helper, T cytotoxic, and the Natural Killer cell numbers were increasing from birth until 6 months, followed by a gradual decrease thereafter. B cell numbers were rising until 2 years, followed by a gradual decrease for the upcoming years, accompanied by a steady expansion of unclass-switched- and class-switched- B cells. We provide updated extensive reference intervals for lymphocyte subpopulations in Turkish people.

26 August 2019 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
CCCecilia Domínguez Conde
Cecilia Domínguez Conde
ÖPÖzlem Yüce Petronczki
Özlem Yüce Petronczki
SBSafa Baris
Safa Baris
KWKatharina Willmann
Katharina Willmann
EGEnrico Girardi
Enrico Girardi
KBKaan Boztug
Kaan Boztug
Polymerase δ is essential for eukaryotic genome duplication and synthesizes DNA at both the leading and lagging strands. The polymerase δ complex is a heterotetramer comprising the catalytic subunit POLD1 and the accessory subunits POLD2, POLD3, and POLD4. Beyond DNA replication, the polymerase δ complex has emerged as a central element in genome maintenance. The essentiality of polymerase δ has constrained the generation of polymerase δ–knockout cell lines or model organisms and, therefore, the understanding of the complexity of its activity and the function of its accessory subunits. To our knowledge, no germline biallelic mutations affecting this complex have been reported in humans. In patients from 2 independent pedigrees, we have identified what we believe to be a novel syndrome with reduced functionality of the polymerase δ complex caused by germline biallelic mutations in POLD1 or POLD2 as the underlying etiology of a previously unknown autosomal-recessive syndrome that combines replicative stress, neurodevelopmental abnormalities, and immunodeficiency. Patients’ cells showed impaired cell-cycle progression and replication-associated DNA lesions that were reversible upon overexpression of polymerase δ. The mutations affected the stability and interactions within the polymerase δ complex or its intrinsic polymerase activity. We believe our discovery of human polymerase δ deficiency identifies the central role of this complex in the prevention of replication-related DNA lesions, with particular relevance to adaptive immunity.

4 January 2021 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
AOAhmet Ozen
Ahmet Ozen
NKNurhan Kasap
Nurhan Kasap
IVIvan Vujkovic-Cvijin
Ivan Vujkovic-Cvijin
RARichard Apps
Richard Apps
FCFoo Cheung
Foo Cheung
MLMichael J. Lenardo
Michael J. Lenardo

15 July 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ANAnna-Lena Neehus
Anna-Lena Neehus
KMKunihiko Moriya
Kunihiko Moriya
ANAlejandro Nieto-Patlán
Alejandro Nieto-Patlán
TVTom Le Voyer
Tom Le Voyer
RLRomain Lévy
Romain Lévy
JBJacinta Bustamante
Jacinta Bustamante
Patients with autosomal recessive protein kinase C δ (PKCδ) deficiency suffer from childhood-onset autoimmunity, including systemic lupus erythematosus. They also suffer from recurrent infections that overlap with those seen in patients with chronic granulomatous disease (CGD), a disease caused by defects of the phagocyte NADPH oxidase and a lack of reactive oxygen species (ROS) production. We studied an international cohort of 17 PKCδ-deficient patients and found that their EBV-B cells and monocyte-derived phagocytes produced only small amounts of ROS and did not phosphorylate p40phox normally after PMA or opsonized Staphylococcus aureus stimulation. Moreover, the patients’ circulating phagocytes displayed abnormally low levels of ROS production and markedly reduced neutrophil extracellular trap formation, altogether suggesting a role for PKCδ in activation of the NADPH oxidase complex. Our findings thus show that patients with PKCδ deficiency have impaired NADPH oxidase activity in various myeloid subsets, which may contribute to their CGD-like infectious phenotype.